COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01919346
Recruitment Status : Terminated (Based on results from Alexion PROTECT DGF study)
First Posted : August 9, 2013
Last Update Posted : February 27, 2018
Alexion Pharmaceuticals
Icahn School of Medicine at Mount Sinai
Information provided by (Responsible Party):
Heeger, Peter, M.D.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2017
Actual Study Completion Date : December 2017